Watch CBS News

Biotech Company Plans To Split Its 2 Businesses In Spin-off

GAITHERSBURG, Md. (AP) -- A biotechnology company has announced that it plans to split its research and manufacturing businesses into two companies.

The Baltimore Sun reports Emergent BioSolutions made the announcement Thursday. Company officials say Emergent will maintain its production facility in Baltimore.

The Gaithersburg-based Emergent is looking to spin-off the research business into a stand-alone public company, which will work to develop treatments for cancer and blood diseases.

The move will help Emergent to increase profit as company leaders look to expand their growth in biodefense and preparedness for emerging infectious diseases.

CEO Daniel J. Abdun-Nabi says they expect the proposed spin-off to enhance business focus and unlock significant value for both companies.

Emergent has two facilities in Baltimore, among five sites where it develops and produces biodefense agents and other products.

(Copyright 2015 by The Associated Press. All Rights Reserved.)

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.